Close

Registration is free and only takes a moment. If you have already registered, please log in now.

Create Account
Forgot your password?
Log In
  • Links
  • Aggregator Full Text
  • MESH
  • Cognition Disorders
  • Diabetes Mellitus, Type 2
  • Drug Interactions
  • Drug Labeling
  • Drug-Induced Liver Injury
  • Glucose Intolerance
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Randomized Controlled Trials as Topic
  • United States
  • United States Food and Drug Administration

Unbound MEDLINE

Changes to the statin label: what they really mean.

Links

  • Aggregator Full Text
  • Source

    Harvard health letter / from Harvard Medical School 37:7 2012 May pg 5

    MeSH

    Cognition Disorders
    Diabetes Mellitus, Type 2
    Drug Interactions
    Drug Labeling
    Drug-Induced Liver Injury
    Glucose Intolerance
    Humans
    Hydroxymethylglutaryl-CoA Reductase Inhibitors
    Randomized Controlled Trials as Topic
    United States
    United States Food and Drug Administration

    Pub Type(s)

    Journal Article

    Language

    eng

    PubMed ID

    22737739

    Related Citations

    • Statin label changes.
    • Increased risk of glucose intolerance and type 2 diabetes with statins.
    • Statin use and the risk of developing diabetes. Study confirms a link, but does the risk outweigh the benefits?
    • The controversies of statin therapy: weighing the evidence.
    • Risk of diabetes from statins may be higher in women.
    • Statin-induced diabetes: perhaps, it's the tip of the iceberg.
    • New analysis supports expanded use of statins in women.
    • Statin-induced diabetes: will it change clinical practice?
    More
    unbound logo
    • Home »
    • Contact Us »
    • Help »
    • Privacy / Disclaimer »
    • Terms of Service »
    • Log In »
    • twitter
    • facebook
    © 2000–2013 Unbound Medicine, Inc. All rights reserved